認知神経科学の2030年までの市場予測： タイプ別、コンポーネント別、用途別、地域別の世界分析

Stratistics MRCによると、認知神経科学の世界市場は2023年に367億2,000万米ドルを占め、予測期間中にCAGR 8％で成長し、2030年には629億3,000万米ドルに達すると予測されています。

知覚、記憶、言語、意思決定、問題解決など、人間の認知を支える神経学的プロセスを理解することが、認知神経科学の学際的研究の焦点です。認知神経科学は、心理学、神経学、その他の関連分野の要素を統合し、脳がさまざまな認知プロセスをどのように管理しているかを研究します。政府の目標、公共の関心、金銭的な状況に基づいて、資金調達のレベルは変わるかもしれないです。製薬会社の中には、認知プロセスをターゲットにした薬や治療法を開発するところもあり、アルツハイマー病やADHDの治療、認知能力の強化に役立つかもしれないです。

パーキンソン財団の団体によると、米国では2020年末までに約100万人がパーキンソン病（PD）を患い、毎年6万人近くの米国人がパーキンソン病と診断されています。

神経画像技術の進歩

認知神経科学の市場は、ニューロイメージング技術の開拓によって大きく形成され、牽引されてきました。これらの開発により、研究者は人間の認知や行動の神経学的基盤についてより深く知ることができるようになっています。MRI技術の向上により、高解像度の構造的・機能的脳イメージングが可能になっています。さらに、高磁場MRIスキャナ（3Tや7Tなど）の強力な磁場は、脳の構造や機能的活動をより正確で優れた画像にします。マルチバンドイメージングや迅速な撮影方法など、fMRI技術の進歩により、調査者はより高い時間分解能で脳活動を記録できるようになっています。

装置と技術のコスト

研究や臨床評価を実施しようとする研究者、大学、組織にとって、認知神経科学業界の機器や技術の価格は大きな障害となりうる。認知神経科学研究で使用される機械や技術の専門的で最先端な性質が、高額な費用の主な原因です。3テスラ（3T）や7テスラ（7T）のような高磁場MRIスキャナーの購入・維持費は高額です。ラジオトレーサー、PETスキャナー、施設の維持費も高いかもしれないです。データ解析のための専用ハードウェアを備えた高性能コンピュータの購入には費用がかかります。ニューロイメージングやデータ処理用の専用ソフトウェアツールにはライセンシングコストがかかることが多く、これが市場の成長を妨げています。

認知機能の強化とパフォーマンスの最適化

認知神経科学は、学習結果を向上させる手法やリソースを提供するため、教育分野にも利用されています。個別学習のためのプラットフォームや適応可能な教材は、こうした戦略の一部です。認知神経科学の市場には、ストレスを和らげ、感情制御を強化し、認知機能に直接影響を与える可能性があるため、メンタルタフネスを高める戦略も含まれます。軍人、スポーツ選手、企業のリーダーなど、さまざまな分野の専門家向けに、いくつかの組織が特定のトレーニングプログラムを提供しています。認知プロセスをターゲットにした薬の開発研究も続けられています。これらの薬は、記憶力、集中力、その他の認知機能を改善することを目的としています。これらの薬物は、治療的な状況や健康な人の認知機能を改善するために適用することができます。

倫理的および規制上の考慮点

認知神経科学の研究開発に必要な時間は、倫理的・規制的評価によって大幅に増加する可能性があります。倫理的許可の取得や規制手続きの交渉により、研究の開始時期や終了時期が遅れ、科学的進歩の速度が遅くなる可能性があります。倫理的・法的義務を遵守する代償は、時に高くつく。これには、適切な調査方法を維持するための費用、法令遵守のための管理費、倫理審査委員会の委員費用などが含まれます。さらに、研究者は海外のさまざまな規則や倫理的要件を管理しなければならないことが多いため、国境を越えた研究を行うことは、論理的にも管理上も困難な場合があります。

COVID-19影響

ロックダウン、社会的距離の取り方、研究室や調査業務の制限により、いくつかの認知神経科学の研究プロジェクトや調査が中止または延期されました。研究施設へのアクセスや参加者の募集は研究者にとって困難であり、プロジェクトの期間やデータ収集に影響を与えた可能性があります。政府や組織は、流行の結果、支出を削減し、研究を後援する優先順位を並べ替えました。認知神経科学の研究資金がCOVID-19関連のイニシアチブに流用されたケースもあると思われます。

予測期間中、脳造影（EEC）分野が最大となる見込み

脳造影（EEC）セグメントは、注意、記憶、言語、感情など、いくつかの認知機能に関連する脳活動を調べるために頻繁に使用されるため、有利な成長を遂げると推定されます。EECデータを分析するためのソフトウェアと方法は、認知神経科学の研究者にとって極めて重要です。これらのプログラムは、認知活動中の脳の働きに関する知識を得るために、そのデータの処理と分析を可能にします。ニューロフィードバックでは、脳の活動をコントロールしたり、修正したりする方法を教えるために、EECを使用してリアルタイムフィードバックを行う。この用途には、認知機能の改善やストレスの軽減などがあり、市場の成長を後押ししています。

予測期間中にCAGRが最も高くなると予測される機器分野

脳の活動、行動、認知の研究は、認知神経科学で使用されるツールに大きく依存しているため、機器分野は予測期間中に最も高いCAGR成長が見込まれます。いくつかの研究および臨床応用におけるデータ収集、処理、解釈のために、これらのツールは極めて重要です。神経画像装置、脳波計（EEG）、経頭蓋磁気刺激（TMS）、経頭蓋直流電流刺激（tDCS）は、認知神経科学分野で頻繁に使用される装置や技術の一部です。さらに、よりポータブルで安価なニューロイメージング技術や、より優れたデータ解析方法の開発など、絶え間ない技術進歩が認知神経科学機器の市場を特徴づけています。これらの機器は、認知プロセス、脳の病気、認知改善やリハビリテーションのための将来的な治療法について、研究および治療の両方の場面で詳しく知るために頻繁に使用されています。

最大のシェアを占める地域

アジア太平洋地域が予測期間中最大の市場シェアを占めると予測されるが、これは同地域の認知症罹患率の上昇が市場成長の主な原因であると考えられるからです。認知症患者の割合が最も高いのはアジア太平洋地域であると考えられています。人口の高齢化に伴い認知症患者は増加すると予測されており、同地域における認知神経科学の需要を押し上げると予測されています。例えば、認知神経科学は神経経路に関する洞察を提供することで、認知症の予防と治療に役立ちます。

CAGRが最も高い地域：

北米は予測期間中にCAGRが最も高くなると予測されています。この地域では不安やうつ病の有病率が上昇しているため、認知神経科学のニーズが増加しており、この地域での市場拡大も予測されています。例えば米国では、4.91％の人が重度の精神疾患を抱えています。州別では、成人の精神疾患の有病率はニュージャージー州の16.37％からユタ州の26.86％に及び、これが市場の成長を後押ししています。

無料カスタマイズサービス：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

• 企業プロファイル
  • 追加市場プレイヤーの包括的プロファイリング（3社まで）
  • 主要企業のSWOT分析（3社まで）
• 地域セグメンテーション
  • 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
• 競合ベンチマーキング
  • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

• 概要
• ステークホルダー
• 調査範囲
• 調査手法
  • データマイニング
  • データ分析
  • データ検証
  • 調査アプローチ
• 調査ソース
  • 1次調査ソース
  • 2次調査ソース
  • 前提条件

第3章 市場動向分析

• 促進要因
• 抑制要因
• 機会
• 脅威
• アプリケーション分析
• エンドユーザー分析
• 新興市場
• 新型コロナウイルス感染症（COVID-19）の影響

第4章 ポーターのファイブフォース分析

• 供給企業の交渉力
• 買い手の交渉力
• 代替品の脅威
• 新規参入業者の脅威
• 競争企業間の敵対関係

第5章 世界の認知神経科学市場：タイプ別

• 機能的磁気共鳴画像法（fMRI）
• 脳波検査（EEC）
• 近赤外分光法（NIRS）
• 磁気共鳴画像法（MRI）
• 脳磁図（MEG）
• 単一光子放射コンピュータ断層撮影法（SPECT）
• 陽電子放出断層撮影法（PET）
• その他のタイプ

第6章 世界の認知神経科学市場：コンポーネント別

• 楽器
• 消耗品
• ソフトウェアとサービス

第7章 世界の認知神経科学市場：アプリケーション別

• 神経学的調査
• 脳画像検査
• 神経学的障害
• 精神科
• その他の用途

第8章 世界の認知神経科学市場：エンドユーザー別

• 臨床および調査機関
• 製薬会社
• 学術調査機関
• 病院および病理学研究所
• その他のエンドユーザー

第9章 世界の認知神経科学市場：地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン
  • その他欧州
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • オーストラリア
  • ニュージーランド
  • 韓国
  • その他アジア太平洋地域
• 南米
  • アルゼンチン
  • ブラジル
  • チリ
  • その他南米
• 中東とアフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • カタール
  • 南アフリカ
  • その他中東とアフリカ

第10章 主な発展

• 契約、パートナーシップ、コラボレーション、合弁事業
• 買収と合併
• 新製品の発売
• 事業拡大
• その他の主要戦略

第11章 企業プロファイル

• Danaher Corp
• Carl Zeiss AG
• Siemens Healthcare Private Limited
• Canon Inc
• Medtronic
• Stryker
• Boston Scientific Corp
• ABBOTT
• Koninklijke Philips N.V
• Terumo Corp
• B. Braun SE
• Alpha Omega Inc.
• Biobserve GmbH
• NeuroNexus Technology
• Laserglow Technologies
• Kendall Research Systems LLC
• Scientifica Ltd.

List of Tables

• Table 1 Global Cognitive Neuroscience Market Outlook, By Region (2021-2030) ($MN)
• Table 2 Global Cognitive Neuroscience Market Outlook, By Type (2021-2030) ($MN)
• Table 3 Global Cognitive Neuroscience Market Outlook, By Functional Magnetic Resonance Imaging (fMRI) (2021-2030) ($MN)
• Table 4 Global Cognitive Neuroscience Market Outlook, By Encephalography (EEC) (2021-2030) ($MN)
• Table 5 Global Cognitive Neuroscience Market Outlook, By Near Infrared Spectroscopy (NIRS) (2021-2030) ($MN)
• Table 6 Global Cognitive Neuroscience Market Outlook, By Magnetic Resonance Imaging (MRI) (2021-2030) ($MN)
• Table 7 Global Cognitive Neuroscience Market Outlook, By Magnetoencephalography (MEG) (2021-2030) ($MN)
• Table 8 Global Cognitive Neuroscience Market Outlook, By Single Photon Emission Computed Tomography (SPECT) (2021-2030) ($MN)
• Table 9 Global Cognitive Neuroscience Market Outlook, By Positron Emission Tomography (PET) (2021-2030) ($MN)
• Table 10 Global Cognitive Neuroscience Market Outlook, By Other Types (2021-2030) ($MN)
• Table 11 Global Cognitive Neuroscience Market Outlook, By Component (2021-2030) ($MN)
• Table 12 Global Cognitive Neuroscience Market Outlook, By Instruments (2021-2030) ($MN)
• Table 13 Global Cognitive Neuroscience Market Outlook, By Consumables (2021-2030) ($MN)
• Table 14 Global Cognitive Neuroscience Market Outlook, By Software & Services (2021-2030) ($MN)
• Table 15 Global Cognitive Neuroscience Market Outlook, By Application (2021-2030) ($MN)
• Table 16 Global Cognitive Neuroscience Market Outlook, By Neurological Research (2021-2030) ($MN)
• Table 17 Global Cognitive Neuroscience Market Outlook, By Brain Imaging (2021-2030) ($MN)
• Table 18 Global Cognitive Neuroscience Market Outlook, By Neurological Disorders (2021-2030) ($MN)
• Table 19 Global Cognitive Neuroscience Market Outlook, By Psychiatry (2021-2030) ($MN)
• Table 20 Global Cognitive Neuroscience Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 21 Global Cognitive Neuroscience Market Outlook, By End User (2021-2030) ($MN)
• Table 22 Global Cognitive Neuroscience Market Outlook, By Clinical & Research Laboratories (2021-2030) ($MN)
• Table 23 Global Cognitive Neuroscience Market Outlook, By Pharmaceutical Companies (2021-2030) ($MN)
• Table 24 Global Cognitive Neuroscience Market Outlook, By Academic Research Institutes (2021-2030) ($MN)
• Table 25 Global Cognitive Neuroscience Market Outlook, By Hospitals & Pathology Laboratories (2021-2030) ($MN)
• Table 26 Global Cognitive Neuroscience Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 27 North America Cognitive Neuroscience Market Outlook, By Country (2021-2030) ($MN)
• Table 28 North America Cognitive Neuroscience Market Outlook, By Type (2021-2030) ($MN)
• Table 29 North America Cognitive Neuroscience Market Outlook, By Functional Magnetic Resonance Imaging (fMRI) (2021-2030) ($MN)
• Table 30 North America Cognitive Neuroscience Market Outlook, By Encephalography (EEC) (2021-2030) ($MN)
• Table 31 North America Cognitive Neuroscience Market Outlook, By Near Infrared Spectroscopy (NIRS) (2021-2030) ($MN)
• Table 32 North America Cognitive Neuroscience Market Outlook, By Magnetic Resonance Imaging (MRI) (2021-2030) ($MN)
• Table 33 North America Cognitive Neuroscience Market Outlook, By Magnetoencephalography (MEG) (2021-2030) ($MN)
• Table 34 North America Cognitive Neuroscience Market Outlook, By Single Photon Emission Computed Tomography (SPECT) (2021-2030) ($MN)
• Table 35 North America Cognitive Neuroscience Market Outlook, By Positron Emission Tomography (PET) (2021-2030) ($MN)
• Table 36 North America Cognitive Neuroscience Market Outlook, By Other Types (2021-2030) ($MN)
• Table 37 North America Cognitive Neuroscience Market Outlook, By Component (2021-2030) ($MN)
• Table 38 North America Cognitive Neuroscience Market Outlook, By Instruments (2021-2030) ($MN)
• Table 39 North America Cognitive Neuroscience Market Outlook, By Consumables (2021-2030) ($MN)
• Table 40 North America Cognitive Neuroscience Market Outlook, By Software & Services (2021-2030) ($MN)
• Table 41 North America Cognitive Neuroscience Market Outlook, By Application (2021-2030) ($MN)
• Table 42 North America Cognitive Neuroscience Market Outlook, By Neurological Research (2021-2030) ($MN)
• Table 43 North America Cognitive Neuroscience Market Outlook, By Brain Imaging (2021-2030) ($MN)
• Table 44 North America Cognitive Neuroscience Market Outlook, By Neurological Disorders (2021-2030) ($MN)
• Table 45 North America Cognitive Neuroscience Market Outlook, By Psychiatry (2021-2030) ($MN)
• Table 46 North America Cognitive Neuroscience Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 47 North America Cognitive Neuroscience Market Outlook, By End User (2021-2030) ($MN)
• Table 48 North America Cognitive Neuroscience Market Outlook, By Clinical & Research Laboratories (2021-2030) ($MN)
• Table 49 North America Cognitive Neuroscience Market Outlook, By Pharmaceutical Companies (2021-2030) ($MN)
• Table 50 North America Cognitive Neuroscience Market Outlook, By Academic Research Institutes (2021-2030) ($MN)
• Table 51 North America Cognitive Neuroscience Market Outlook, By Hospitals & Pathology Laboratories (2021-2030) ($MN)
• Table 52 North America Cognitive Neuroscience Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 53 Europe Cognitive Neuroscience Market Outlook, By Country (2021-2030) ($MN)
• Table 54 Europe Cognitive Neuroscience Market Outlook, By Type (2021-2030) ($MN)
• Table 55 Europe Cognitive Neuroscience Market Outlook, By Functional Magnetic Resonance Imaging (fMRI) (2021-2030) ($MN)
• Table 56 Europe Cognitive Neuroscience Market Outlook, By Encephalography (EEC) (2021-2030) ($MN)
• Table 57 Europe Cognitive Neuroscience Market Outlook, By Near Infrared Spectroscopy (NIRS) (2021-2030) ($MN)
• Table 58 Europe Cognitive Neuroscience Market Outlook, By Magnetic Resonance Imaging (MRI) (2021-2030) ($MN)
• Table 59 Europe Cognitive Neuroscience Market Outlook, By Magnetoencephalography (MEG) (2021-2030) ($MN)
• Table 60 Europe Cognitive Neuroscience Market Outlook, By Single Photon Emission Computed Tomography (SPECT) (2021-2030) ($MN)
• Table 61 Europe Cognitive Neuroscience Market Outlook, By Positron Emission Tomography (PET) (2021-2030) ($MN)
• Table 62 Europe Cognitive Neuroscience Market Outlook, By Other Types (2021-2030) ($MN)
• Table 63 Europe Cognitive Neuroscience Market Outlook, By Component (2021-2030) ($MN)
• Table 64 Europe Cognitive Neuroscience Market Outlook, By Instruments (2021-2030) ($MN)
• Table 65 Europe Cognitive Neuroscience Market Outlook, By Consumables (2021-2030) ($MN)
• Table 66 Europe Cognitive Neuroscience Market Outlook, By Software & Services (2021-2030) ($MN)
• Table 67 Europe Cognitive Neuroscience Market Outlook, By Application (2021-2030) ($MN)
• Table 68 Europe Cognitive Neuroscience Market Outlook, By Neurological Research (2021-2030) ($MN)
• Table 69 Europe Cognitive Neuroscience Market Outlook, By Brain Imaging (2021-2030) ($MN)
• Table 70 Europe Cognitive Neuroscience Market Outlook, By Neurological Disorders (2021-2030) ($MN)
• Table 71 Europe Cognitive Neuroscience Market Outlook, By Psychiatry (2021-2030) ($MN)
• Table 72 Europe Cognitive Neuroscience Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 73 Europe Cognitive Neuroscience Market Outlook, By End User (2021-2030) ($MN)
• Table 74 Europe Cognitive Neuroscience Market Outlook, By Clinical & Research Laboratories (2021-2030) ($MN)
• Table 75 Europe Cognitive Neuroscience Market Outlook, By Pharmaceutical Companies (2021-2030) ($MN)
• Table 76 Europe Cognitive Neuroscience Market Outlook, By Academic Research Institutes (2021-2030) ($MN)
• Table 77 Europe Cognitive Neuroscience Market Outlook, By Hospitals & Pathology Laboratories (2021-2030) ($MN)
• Table 78 Europe Cognitive Neuroscience Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 79 Asia Pacific Cognitive Neuroscience Market Outlook, By Country (2021-2030) ($MN)
• Table 80 Asia Pacific Cognitive Neuroscience Market Outlook, By Type (2021-2030) ($MN)
• Table 81 Asia Pacific Cognitive Neuroscience Market Outlook, By Functional Magnetic Resonance Imaging (fMRI) (2021-2030) ($MN)
• Table 82 Asia Pacific Cognitive Neuroscience Market Outlook, By Encephalography (EEC) (2021-2030) ($MN)
• Table 83 Asia Pacific Cognitive Neuroscience Market Outlook, By Near Infrared Spectroscopy (NIRS) (2021-2030) ($MN)
• Table 84 Asia Pacific Cognitive Neuroscience Market Outlook, By Magnetic Resonance Imaging (MRI) (2021-2030) ($MN)
• Table 85 Asia Pacific Cognitive Neuroscience Market Outlook, By Magnetoencephalography (MEG) (2021-2030) ($MN)
• Table 86 Asia Pacific Cognitive Neuroscience Market Outlook, By Single Photon Emission Computed Tomography (SPECT) (2021-2030) ($MN)
• Table 87 Asia Pacific Cognitive Neuroscience Market Outlook, By Positron Emission Tomography (PET) (2021-2030) ($MN)
• Table 88 Asia Pacific Cognitive Neuroscience Market Outlook, By Other Types (2021-2030) ($MN)
• Table 89 Asia Pacific Cognitive Neuroscience Market Outlook, By Component (2021-2030) ($MN)
• Table 90 Asia Pacific Cognitive Neuroscience Market Outlook, By Instruments (2021-2030) ($MN)
• Table 91 Asia Pacific Cognitive Neuroscience Market Outlook, By Consumables (2021-2030) ($MN)
• Table 92 Asia Pacific Cognitive Neuroscience Market Outlook, By Software & Services (2021-2030) ($MN)
• Table 93 Asia Pacific Cognitive Neuroscience Market Outlook, By Application (2021-2030) ($MN)
• Table 94 Asia Pacific Cognitive Neuroscience Market Outlook, By Neurological Research (2021-2030) ($MN)
• Table 95 Asia Pacific Cognitive Neuroscience Market Outlook, By Brain Imaging (2021-2030) ($MN)
• Table 96 Asia Pacific Cognitive Neuroscience Market Outlook, By Neurological Disorders (2021-2030) ($MN)
• Table 97 Asia Pacific Cognitive Neuroscience Market Outlook, By Psychiatry (2021-2030) ($MN)
• Table 98 Asia Pacific Cognitive Neuroscience Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 99 Asia Pacific Cognitive Neuroscience Market Outlook, By End User (2021-2030) ($MN)
• Table 100 Asia Pacific Cognitive Neuroscience Market Outlook, By Clinical & Research Laboratories (2021-2030) ($MN)
• Table 101 Asia Pacific Cognitive Neuroscience Market Outlook, By Pharmaceutical Companies (2021-2030) ($MN)
• Table 102 Asia Pacific Cognitive Neuroscience Market Outlook, By Academic Research Institutes (2021-2030) ($MN)
• Table 103 Asia Pacific Cognitive Neuroscience Market Outlook, By Hospitals & Pathology Laboratories (2021-2030) ($MN)
• Table 104 Asia Pacific Cognitive Neuroscience Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 105 South America Cognitive Neuroscience Market Outlook, By Country (2021-2030) ($MN)
• Table 106 South America Cognitive Neuroscience Market Outlook, By Type (2021-2030) ($MN)
• Table 107 South America Cognitive Neuroscience Market Outlook, By Functional Magnetic Resonance Imaging (fMRI) (2021-2030) ($MN)
• Table 108 South America Cognitive Neuroscience Market Outlook, By Encephalography (EEC) (2021-2030) ($MN)
• Table 109 South America Cognitive Neuroscience Market Outlook, By Near Infrared Spectroscopy (NIRS) (2021-2030) ($MN)
• Table 110 South America Cognitive Neuroscience Market Outlook, By Magnetic Resonance Imaging (MRI) (2021-2030) ($MN)
• Table 111 South America Cognitive Neuroscience Market Outlook, By Magnetoencephalography (MEG) (2021-2030) ($MN)
• Table 112 South America Cognitive Neuroscience Market Outlook, By Single Photon Emission Computed Tomography (SPECT) (2021-2030) ($MN)
• Table 113 South America Cognitive Neuroscience Market Outlook, By Positron Emission Tomography (PET) (2021-2030) ($MN)
• Table 114 South America Cognitive Neuroscience Market Outlook, By Other Types (2021-2030) ($MN)
• Table 115 South America Cognitive Neuroscience Market Outlook, By Component (2021-2030) ($MN)
• Table 116 South America Cognitive Neuroscience Market Outlook, By Instruments (2021-2030) ($MN)
• Table 117 South America Cognitive Neuroscience Market Outlook, By Consumables (2021-2030) ($MN)
• Table 118 South America Cognitive Neuroscience Market Outlook, By Software & Services (2021-2030) ($MN)
• Table 119 South America Cognitive Neuroscience Market Outlook, By Application (2021-2030) ($MN)
• Table 120 South America Cognitive Neuroscience Market Outlook, By Neurological Research (2021-2030) ($MN)
• Table 121 South America Cognitive Neuroscience Market Outlook, By Brain Imaging (2021-2030) ($MN)
• Table 122 South America Cognitive Neuroscience Market Outlook, By Neurological Disorders (2021-2030) ($MN)
• Table 123 South America Cognitive Neuroscience Market Outlook, By Psychiatry (2021-2030) ($MN)
• Table 124 South America Cognitive Neuroscience Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 125 South America Cognitive Neuroscience Market Outlook, By End User (2021-2030) ($MN)
• Table 126 South America Cognitive Neuroscience Market Outlook, By Clinical & Research Laboratories (2021-2030) ($MN)
• Table 127 South America Cognitive Neuroscience Market Outlook, By Pharmaceutical Companies (2021-2030) ($MN)
• Table 128 South America Cognitive Neuroscience Market Outlook, By Academic Research Institutes (2021-2030) ($MN)
• Table 129 South America Cognitive Neuroscience Market Outlook, By Hospitals & Pathology Laboratories (2021-2030) ($MN)
• Table 130 South America Cognitive Neuroscience Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 131 Middle East & Africa Cognitive Neuroscience Market Outlook, By Country (2021-2030) ($MN)
• Table 132 Middle East & Africa Cognitive Neuroscience Market Outlook, By Type (2021-2030) ($MN)
• Table 133 Middle East & Africa Cognitive Neuroscience Market Outlook, By Functional Magnetic Resonance Imaging (fMRI) (2021-2030) ($MN)
• Table 134 Middle East & Africa Cognitive Neuroscience Market Outlook, By Encephalography (EEC) (2021-2030) ($MN)
• Table 135 Middle East & Africa Cognitive Neuroscience Market Outlook, By Near Infrared Spectroscopy (NIRS) (2021-2030) ($MN)
• Table 136 Middle East & Africa Cognitive Neuroscience Market Outlook, By Magnetic Resonance Imaging (MRI) (2021-2030) ($MN)
• Table 137 Middle East & Africa Cognitive Neuroscience Market Outlook, By Magnetoencephalography (MEG) (2021-2030) ($MN)
• Table 138 Middle East & Africa Cognitive Neuroscience Market Outlook, By Single Photon Emission Computed Tomography (SPECT) (2021-2030) ($MN)
• Table 139 Middle East & Africa Cognitive Neuroscience Market Outlook, By Positron Emission Tomography (PET) (2021-2030) ($MN)
• Table 140 Middle East & Africa Cognitive Neuroscience Market Outlook, By Other Types (2021-2030) ($MN)
• Table 141 Middle East & Africa Cognitive Neuroscience Market Outlook, By Component (2021-2030) ($MN)
• Table 142 Middle East & Africa Cognitive Neuroscience Market Outlook, By Instruments (2021-2030) ($MN)
• Table 143 Middle East & Africa Cognitive Neuroscience Market Outlook, By Consumables (2021-2030) ($MN)
• Table 144 Middle East & Africa Cognitive Neuroscience Market Outlook, By Software & Services (2021-2030) ($MN)
• Table 145 Middle East & Africa Cognitive Neuroscience Market Outlook, By Application (2021-2030) ($MN)
• Table 146 Middle East & Africa Cognitive Neuroscience Market Outlook, By Neurological Research (2021-2030) ($MN)
• Table 147 Middle East & Africa Cognitive Neuroscience Market Outlook, By Brain Imaging (2021-2030) ($MN)
• Table 148 Middle East & Africa Cognitive Neuroscience Market Outlook, By Neurological Disorders (2021-2030) ($MN)
• Table 149 Middle East & Africa Cognitive Neuroscience Market Outlook, By Psychiatry (2021-2030) ($MN)
• Table 150 Middle East & Africa Cognitive Neuroscience Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 151 Middle East & Africa Cognitive Neuroscience Market Outlook, By End User (2021-2030) ($MN)
• Table 152 Middle East & Africa Cognitive Neuroscience Market Outlook, By Clinical & Research Laboratories (2021-2030) ($MN)
• Table 153 Middle East & Africa Cognitive Neuroscience Market Outlook, By Pharmaceutical Companies (2021-2030) ($MN)
• Table 154 Middle East & Africa Cognitive Neuroscience Market Outlook, By Academic Research Institutes (2021-2030) ($MN)
• Table 155 Middle East & Africa Cognitive Neuroscience Market Outlook, By Hospitals & Pathology Laboratories (2021-2030) ($MN)
• Table 156 Middle East & Africa Cognitive Neuroscience Market Outlook, By Other End Users (2021-2030) ($MN)

According to Stratistics MRC, the Global Cognitive Neuroscience Market is accounted for $36.72 billion in 2023 and is expected to reach $62.93 billion by 2030 growing at a CAGR of 8% during the forecast period. Understanding the neurological processes underpinning human cognition, including perception, memory, language, decision-making, and problem-solving, is the focus of the interdisciplinary study of cognitive neuroscience. It integrates components of psychology, neurology, and other relevant fields to look into how the brain manages different cognitive processes. Based on governmental goals, public interest, and monetary situations, the level of financing may change. Some pharmaceutical firms could create medications and therapies that target cognitive processes, which might be useful for treating Alzheimer's disease, ADHD, or enhancing cognitive abilities.

According to the Parkinson's Foundation organization approximately one million people will be living with Parkinson's disease (PD) in the United States by the end of the year 2020, and nearly 60,000 Americans are diagnosed with Parkinson's disease each year.

Market Dynamics:

Driver:

Advancements in neuroimaging technology

The market for cognitive neuroscience has been significantly shaped and driven by developments in neuroimaging technologies. These developments have made it possible for researchers to learn more about the neurological underpinnings of human cognition and behaviour. High-resolution structural and functional brain imaging has been made possible by improvements in MRI technology. Moreover, the stronger magnetic fields in high-field MRI scanners (such the 3T and 7T) produce better, more precise pictures of brain structures and functional activity. Researchers can now record brain activity at a higher temporal resolution because to advancements in fMRI techniques including multiband imaging and quicker acquisition methods.

Restraint:

Cost of equipment and technology

For researchers, universities, and organizations wishing to undertake studies or clinical assessments, the price of equipment and technology in the cognitive neuroscience industry can be a substantial obstacle. The specialized and cutting-edge nature of the machinery and technology used in cognitive neuroscience research is mostly to blame for the high expenses. The cost of purchasing and maintaining high-field MRI scanners, such the 3 Tesla (3T) and 7 Tesla (7T), is high. The price of radiotracers, PET scanners, and facility upkeep might be high. It can be expensive to purchase high-performance computers with specialized hardware for data analysis. Licensing costs are frequently associated with proprietary software tools for neuroimaging and data processing which hampers the growth of the market.

Opportunity:

Cognitive enhancement and performance optimization

Cognitive neuroscience is used to the field of education to provide methods and resources that enhance learning results. Platforms for individualized learning and adaptable instructional materials are some of these strategies. The market for cognitive neuroscience includes strategies to ease stress, enhance emotional control, and increase mental toughness since they can directly affect cognitive function. For professionals in a variety of disciplines, including military people, athletes, and corporate leaders, several organizations provide specific training programs. There is continuing research into the creation of medications that target cognitive processes. These medications aim to improve memory, focus, or other cognitive functions. They can be applied in therapeutic circumstances or to improve cognitive function in healthy people.

Threat:

Ethical and regulatory considerations

The time needed for research and development in cognitive neuroscience might be significantly increased by ethical and regulatory evaluations. Studies' beginning and ending dates may be delayed due to obtaining ethical permission and negotiating regulatory procedures, thereby slowing the rate of scientific advancement. The price of adhering to ethical and legal obligations is sometimes higher. These might include the costs of maintaining appropriate research methods, administrative expenditures for compliance, and fees for ethical review board membership. Moreover, it may be difficult logistically and administratively to undertake cross-border research since researchers frequently have to manage a variety of foreign rules and ethical requirements.

COVID-19 Impact

Lockdowns, social distancing techniques, and limitations on lab and research operations caused several cognitive neuroscience research projects and studies to be halted or postponed. Access to research facilities and participant recruitment were difficult for researchers, which may have impacted project timeframes and data collecting. Governments and organizations cut back on spending and rearranged their priorities for sponsoring research as a result of the epidemic. Research funds for cognitive neuroscience may have been diverted to COVID-19-related initiatives in some cases.

The encephalography (EEC) segment is expected to be the largest during the forecast period

The encephalography (EEC) segment is estimated to have a lucrative growth, as it is frequently used to examine brain activity linked to several cognitive functions, including attention, memory, language, and emotion. Software and methods for analysing EEC data are crucial for cognitive neuroscience researchers. These programs enable the processing and analysis of its data in order to glean knowledge about the functioning of the brain during cognitive activities. In order to teach people how to control or modify their brain activity, neurofeedback employs EEC to present them with real-time feedback. Applications for this include improving cognitive function and reducing stress which boost the growth of the market.

The instruments segment is expected to have the highest CAGR during the forecast period

The instruments segment is anticipated to witness the highest CAGR growth during the forecast period, because the study of brain activity, behaviour, and cognition heavily relies on the tools employed in cognitive neuroscience. For data collection, processing, and interpretation in several research and clinical applications, these tools are crucial. Neuroimaging equipment, electroencephalography (EEG), transcranial magnetic stimulation (TMS), and transcranial direct current stimulation (tDCS) are a few of the frequently used equipment and technologies in the cognitive neuroscience sector. Additionally, continuous technical progress, such as the creation of more portable and inexpensive neuroimaging technologies and better data analysis methods, characterizes the market for cognitive neuroscience instruments. These tools are frequently used to learn more about cognitive processes, brain illnesses, and prospective therapies for cognitive improvement and rehabilitation in both research and therapeutic settings.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing the region's rising incidence of dementia may be largely blamed for the market's growth. The biggest percentage of people worldwide living with dementia is believed to be in the Asia Pacific area. Dementia cases are predicted to increase as the population ages, which are predicted to boost the demand for cognitive neuroscience in the area. For instance, by offering insights into the neurological pathways, cognitive neuroscience aids in the prevention and treatment of dementia.

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period, owing to the rising prevalence of anxiety and depression in the area has led to an increase in the need for cognitive neuroscience, therefore market expansion in the region is also anticipated. For instance, in the United States, 4.91% of people have a severe psychiatric condition. State-by-state, the prevalence of adult mental illnesses ranges from 16.37% in New Jersey to 26.86% in Utah which are propelling the growth of the market.

Key players in the market

Some of the key players profiled in the Cognitive Neuroscience Market include: Danaher Corp, Carl Zeiss AG, Siemens Healthcare Private Limited, Canon Inc, Medtronic, Stryker, Boston Scientific Corp, ABBOTT, Koninklijke Philips N.V, Terumo Corp, B. Braun SE, Alpha Omega Inc., Biobserve GmbH, NeuroNexus Technology, Laserglow Technologies, Kendall Research Systems LLC and Scientifica Ltd.

Key Developments:

In October 2023, ZEISS Medical Technology and Boehringer Ingelheim announced a long-term strategic collaboration to develop predictive analytics to enable early detection of eye diseases and more personalized treatments to prevent vision loss for people with serious eye diseases.

In October 2023, Nanoimprint lithography semiconductor manufacturing system that covers diverse applications with simple patterning mechanism, which executes circuit pattern transfer, the most important semiconductor manufacturing process.

In March 2023, Danaher Corporation a global science and technology innovator, announced a strategic partnership with the University of Pennsylvania (Penn) focusing on cell therapy innovation.

Types Covered:

• Functional Magnetic Resonance Imaging (fMRI)
• Encephalography (EEC)
• Near Infrared Spectroscopy (NIRS)
• Magnetic Resonance Imaging (MRI)
• Magnetoencephalography (MEG)
• Single Photon Emission Computed Tomography (SPECT)
• Positron Emission Tomography (PET)
• Other Types

Components Covered:

• Instruments
• Consumables
• Software & Services

Applications Covered:

• Neurological Research
• Brain Imaging
• Neurological Disorders
• Psychiatry
• Other Applications

End Users Covered:

• Clinical & Research Laboratories
• Pharmaceutical Companies
• Academic Research Institutes
• Hospitals & Pathology Laboratories
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Application Analysis
• 3.7 End User Analysis
• 3.8 Emerging Markets
• 3.9 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Cognitive Neuroscience Market, By Type

• 5.1 Introduction
• 5.2 Functional Magnetic Resonance Imaging (fMRI)
• 5.3 Encephalography (EEC)
• 5.4 Near Infrared Spectroscopy (NIRS)
• 5.5 Magnetic Resonance Imaging (MRI)
• 5.6 Magnetoencephalography (MEG)
• 5.7 Single Photon Emission Computed Tomography (SPECT)
• 5.8 Positron Emission Tomography (PET)
• 5.9 Other Types

6 Global Cognitive Neuroscience Market, By Component

• 6.1 Introduction
• 6.2 Instruments
• 6.3 Consumables
• 6.4 Software & Services

7 Global Cognitive Neuroscience Market, By Application

• 7.1 Introduction
• 7.2 Neurological Research
• 7.3 Brain Imaging
• 7.4 Neurological Disorders
• 7.5 Psychiatry
• 7.6 Other Applications

8 Global Cognitive Neuroscience Market, By End User

• 8.1 Introduction
• 8.2 Clinical & Research Laboratories
• 8.3 Pharmaceutical Companies
• 8.4 Academic Research Institutes
• 8.5 Hospitals & Pathology Laboratories
• 8.6 Other End Users

9 Global Cognitive Neuroscience Market, By Geography

• 9.1 Introduction
• 9.2 North America
  • 9.2.1 US
  • 9.2.2 Canada
  • 9.2.3 Mexico
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 Italy
  • 9.3.4 France
  • 9.3.5 Spain
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 New Zealand
  • 9.4.6 South Korea
  • 9.4.7 Rest of Asia Pacific
• 9.5 South America
  • 9.5.1 Argentina
  • 9.5.2 Brazil
  • 9.5.3 Chile
  • 9.5.4 Rest of South America
• 9.6 Middle East & Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 UAE
  • 9.6.3 Qatar
  • 9.6.4 South Africa
  • 9.6.5 Rest of Middle East & Africa

10 Key Developments

• 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 10.2 Acquisitions & Mergers
• 10.3 New Product Launch
• 10.4 Expansions
• 10.5 Other Key Strategies

11 Company Profiling

• 11.1 Danaher Corp
• 11.2 Carl Zeiss AG
• 11.3 Siemens Healthcare Private Limited
• 11.4 Canon Inc
• 11.5 Medtronic
• 11.6 Stryker
• 11.7 Boston Scientific Corp
• 11.8 ABBOTT
• 11.9 Koninklijke Philips N.V
• 11.10 Terumo Corp
• 11.11 B. Braun SE
• 11.12 Alpha Omega Inc.
• 11.13 Biobserve GmbH
• 11.14 NeuroNexus Technology
• 11.15 Laserglow Technologies
• 11.16 Kendall Research Systems LLC
• 11.17 Scientifica Ltd.